Home > Insider Trading > Filing (0001140361-11-010810)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1124105	Targacept Inc	TRGT	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1295829	S William Caldwell	C/O Targacept, Inc. 200 East First Street, Suite 300 Winston-Salem NC 27101	Svp - Drug Discovery And Dev.	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2011-02-16	16,655	$1.75	24,390	No	4	M	Direct
Common Stock	Disposition	2011-02-16	16,655	$26.52	7,735	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2011-02-16	16,655	$0.00	16,655	$2.93

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
21,250		2019-01-08	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	2,000	Indirect	By Wife

Footnotes

The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.25 to $26.81, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
In addition to the sale price reported, the reporting person received an account credit in the amount of $0.7276 per share due to the broker's failure to execute the sale on the date specified in the reporting person's 10b5-1 plan. The account credit represents the difference between the actual weighted average sales price for the shares sold and the first weighted average sales price for the same number of shares soldon the NASDAQ stock market on February 14, 2011 (the date on which the sale was to have been executed under the 10b5-1 plan).
These shares held by the reporting person's spouse. From April 2006 to July 2010, these shares were held by the reporting person's mother-in-law, who did not share his household, in a brokerage account maintained jointly with a right of survivorship with the reporting person's spouse. The reporting person became aware of the shares when his mother-in-law passed away.
This option vested (vests) in equal installments on the last day of 16 consecutive calendar quarters beginning with March 31, 2009.